References
- A. K. Franz and S. O. Wilson, "Organosilicon Molecules with Medicinal Applications", J. Med. Chem., DOI: 10.1021/jm3010114, 2012.
- M. J. Barnes, R. Conroy, D. J. Miller, J. S. Mills, J. G. Montana, P. K. Pooni, G. A. Showell, L. M. Walsh, and J. B. H. Warneck, "Trimethylsilylpyrazoles as novel inhibitors of p38 MAP kinase: A new use of silicon bioisosteres in medicinal chemistry", Bioorg. Med. Chem. Lett., Vol. 17, pp. 354-357, 2007. https://doi.org/10.1016/j.bmcl.2006.10.044
- S. McN. Sieburth, T. Nittoli, A. M. Mutahi, and L. Guo, "Silanediols: A new class of potent protease inhibitors", Angew. Chem. Int. Ed., Vol. 37, pp. 812-814, 1998. https://doi.org/10.1002/(SICI)1521-3773(19980403)37:6<812::AID-ANIE812>3.0.CO;2-I
-
R. Tacke, V. I. Handmann, R. Bertermann, C. Burschka, M. Penka, and C. Seyfried, "Silaanalogues of high-affinity, selective
$\sigma$ ligands of the spiro[indane- 1,4'-piperidine] type: Syntheses, structures, and pharmacological properties", Organometallics, Vol. 22, pp. 916-924, 2003. https://doi.org/10.1021/om020354u - R. Tacke, T. Heinrich, R. Bertermann, C. Burschka, A. Hamacher, and M. U. Kassack, "Sila-haloperidol: A silicon analogue of the dopamine (D2) receptor antagonist haloperidol", Organometallics, Vol. 23, pp. 4468-4477, 2004. https://doi.org/10.1021/om040067l
- S. J. Cho, "Calculation and application of partial charges", J. Chosun Natural Sci., Vol. 3, pp. 226- 230, 2010.
- S. J. Cho, "Meaning and definition of partial charges", J. Chosun Natural Sci., Vol. 3, pp. 231- 236, 2010.
- G. Kothandan, T. Madhavan , C. G. Gadhe, and S. J. Cho, "Pseudoreceptor: concept and overview", J. Chosun Natural Sci., Vol. 3, pp. 162-167, 2010.
- C. G. Gadhe and S. J. Cho, "Modulation of multidrug resistance in cancer by p-glycoprotein", J. Chosun Natural Sci., Vol. 4, pp. 23-30, 2011.
- S. J. Cho, "Search space reduction techniques in small molecular docking", J. Chosun Natural Sci., Vol. 3, pp. 143-147, 2010.
- H. W. Chung and S. J. Cho, "Recent development of scoring functions on small molecular docking", J. Chosun Natural Sci., Vol. 3, pp. 49-53, 2010.
- G. A. Showell and J. S. Mills, "Chemistry challenges in lead optimization: Silicon isosteres in drug discovery", Drug Discov. Today, Vol. 8, pp. 551- 556, 2003. https://doi.org/10.1016/S1359-6446(03)02726-0
- P. K. Pooni and G. A. Showell, "Silicon switches of marketed drugs", Mini-Rev. Med. Chem., Vol. 6, pp. 1169-1177, 2006. https://doi.org/10.2174/138955706778560120
- A. K. Franz, "The synthesis of biologically active organosilicon small molecules", Curr. Opin. Drug Discovery Dev., Vol. 10, pp. 654-671, 2007.
- S. McN. Sieburth and C.-A. Chen, "Silanediol protease inhibitors: From conception to validation", Eur. J. Org. Chem., Vol. 2006, pp. 311-322, 2006. https://doi.org/10.1002/ejoc.200500508
- S. Gately and R. West, "Novel therapeutics with enhanced biological activity generated by the strategic introduction of silicon isosteres into known drug scaffolds", Drug Dev. Res., Vol. 68, pp. 156- 163, 2007. https://doi.org/10.1002/ddr.20177
- W. Bains and R. Tacke, "Silicon chemistry as a novel source of chemical diversity in drug design", Curr. Opin. Drug Discovery Dev., Vol. 6, pp. 526- 543, 2003.
- F. D. Osterholtz and E. R. Pohl, "Kinetics of the hydrolysis and condensation of organofunctional alkoxysilanes: A review", J. Adhes. Sci. Technol., Vol. 6, pp. 127-149, 1992. https://doi.org/10.1163/156856192X00106
- J. S. Mills and G. A. Showell, "Exploitation of silicon medicinal chemistry in drug discovery", Expert Opin. Invest. Drugs, Vol. 13, pp. 1149-1157, 2004. https://doi.org/10.1517/13543784.13.9.1149
- F. T. Chiu, Y. H. Chang, G. Ozkan, G. Zon, K. C. Fichter, and L. R. Phillips, "Synthesis, hydrolytic reactivity, and anticancer evaluation of N- and O-triorganosilylated compounds as new types of potential prodrugs", J. Pharm. Sci., Vol. 71, pp. 542-551, 1982. https://doi.org/10.1002/jps.2600710517
- T. Johansson, L. Weidolf, F. Popp, R. Tacke, and U. Jurva, "In vitro metabolism of haloperidol and silahaloperidol: New metabolic pathways resulting from carbon/silicon exchange", Drug Metab. Dispos., Vol. 38, pp. 73-83, 2010. https://doi.org/10.1124/dmd.109.028449
- M. C. Parrott, M. Finniss, J. C. Luft, A. Pandya, A. Gullapalli, M. E. Napier, and J. M. DeSimone, "Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles", J. Am. Chem. Soc., Vol. 134, pp. 7978-7982, 2012. https://doi.org/10.1021/ja301710z
- J. O. Daiss, C. Burschka, J. S. Mills, J. G. Montana, G. A. Showell, I. Fleming, C. Gaudon, D. Ivanova, H. Gronemeyer, and R. Tacke, "Synthesis, crystal structure analysis, and pharmacological characterization of disila-bexarotene, a disila-analogue of the RXR-selective retinoid agonist bexarotene", Organometallics, Vol. 24, pp. 3192-3199, 2005. https://doi.org/10.1021/om040143k
- J. O. Daiss, C. Burschka, J. S. Mills, J. G. Montana, G. A. Showell, J. B. H. Warneck, and R. Tacke, "Sila-venlafaxine, a sila-analogue of the serotonin/ noradrenaline reuptake inhibitor venlafaxine: Synthesis, crystal structure analysis, and pharmacological characterization", Organometallics, Vol. 25, pp. 1188-1198, 2006. https://doi.org/10.1021/om058051y
- M. Chang, S.-R. Park, J. Kim, M. Jang, J. H. Park, J. E. Park, H.-G. Park, Y.-G. Suh, Y. S. Jeong, Y.- H. Park, and H.-D. Kim, "Silicon switch approach in TRPV1 antagonist MK-056and its analogues", Bioorg. Med. Chem., Vol. 18, pp. 111-116, 2010. https://doi.org/10.1016/j.bmc.2009.11.014
- J. O. Daiss, C. Burschka, J. S. Mills, J. G. Montana, G. A. Showell, J. B. H. Warneck, and R. Tacke, "Sila-venlafaxine, a sila-analogue of the serotonin/ noradrenaline reuptake inhibitor venlafaxine: Synthesis, crystal structure analysis, and pharmacological characterization", Organometallics, Vol. 25, pp. 1188-1198, 2006. https://doi.org/10.1021/om058051y
- M. Blunder, N. Hurkes, S. Spirk, M. List, and Pietschnig, R. "Silanetriols as in vitro inhibitors for AChE", Bioorg. Med. Chem. Lett., Vol. 21, pp. 363- 365, 2011. https://doi.org/10.1016/j.bmcl.2010.10.139
- Y.-M. Kim, S. Farrah, and R. H. Baney, "Structureantimicrobial activity relationship for silanols, a new class of disinfectants, compared with alcohols and phenols", Int. J. Antimicrob. Agents, Vol. 29, pp. 217-222, 2007. https://doi.org/10.1016/j.ijantimicag.2006.08.036
Cited by
- Ligand-Based CoMFA Study on Pyridylpyrazolopyridine Derivatives as PKCθ Kinase Inhibitors vol.7, pp.4, 2014, https://doi.org/10.13160/ricns.2014.7.4.253
- 3D-QSAR Study on Imidazopyridazines Derivatives as Potent Pim-1 Kinase Inhibitors using Region-Focused CoMFA vol.10, pp.2, 2012, https://doi.org/10.13160/ricns.2017.10.2.95
- Synthesis and structural features of N-[(2-(trimethylsilyl)oxy)phenyl]-arylsulfonamides vol.1198, pp.None, 2012, https://doi.org/10.1016/j.molstruc.2019.07.029
- In Water: Green Chemical Approach of 4-Iodo-3-(Trimethylsilyl)-1H-Pyrano[4,3-b]Quinolines through 1,3-Diiodo-5,5-Dimethylhydantoin (DIH) Mediated Regioselective Electrophilic Cyclisation of O-Alkynyl vol.12, pp.9, 2012, https://doi.org/10.1007/s12633-019-00304-4